Cargando…
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190873/ https://www.ncbi.nlm.nih.gov/pubmed/34120766 http://dx.doi.org/10.1016/j.vaccine.2021.05.095 |
| _version_ | 1783705770237362176 |
|---|---|
| author | Dal-Ré, Rafael Launay, Odile |
| author_facet | Dal-Ré, Rafael Launay, Odile |
| author_sort | Dal-Ré, Rafael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8190873 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81908732021-06-10 Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label Dal-Ré, Rafael Launay, Odile Vaccine Commentary Elsevier Ltd. 2021-07-05 2021-06-04 /pmc/articles/PMC8190873/ /pubmed/34120766 http://dx.doi.org/10.1016/j.vaccine.2021.05.095 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Dal-Ré, Rafael Launay, Odile Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title | Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title_full | Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title_fullStr | Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title_full_unstemmed | Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title_short | Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
| title_sort | public trust on regulatory decisions: the european medicines agency and the astrazeneca covid-19 vaccine label |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190873/ https://www.ncbi.nlm.nih.gov/pubmed/34120766 http://dx.doi.org/10.1016/j.vaccine.2021.05.095 |
| work_keys_str_mv | AT dalrerafael publictrustonregulatorydecisionstheeuropeanmedicinesagencyandtheastrazenecacovid19vaccinelabel AT launayodile publictrustonregulatorydecisionstheeuropeanmedicinesagencyandtheastrazenecacovid19vaccinelabel |